000 | 00884 a2200253 4500 | ||
---|---|---|---|
005 | 20250512013556.0 | ||
264 | 0 | _c19900302 | |
008 | 199003s 0 0 eng d | ||
022 | _a0305-7453 | ||
024 | 7 |
_a10.1093/jac/24.4.477 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHawkey, P M | |
245 | 0 | 0 |
_aWhere are we now with ciprofloxacin? _h[electronic resource] |
260 |
_bThe Journal of antimicrobial chemotherapy _cOct 1989 |
||
300 |
_a477-80 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBacteria _xdrug effects |
650 | 0 | 4 |
_aBacterial Infections _xdrug therapy |
650 | 0 | 4 |
_aCiprofloxacin _xpharmacology |
650 | 0 | 4 | _aHumans |
773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 24 _gno. 4 _gp. 477-80 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/24.4.477 _zAvailable from publisher's website |
999 |
_c2699309 _d2699309 |